Should women with early breast cancer under 40 years of age have a routine 21-gene recurrence score testing: A SEER database study

Should women with early breast cancer under 40 years of age have a routine 21-gene recurrence score testing: A SEER database study

Purpose: To investigate the effect of 21-gene recurrence score (RS) on chemotherapy-decision making and prognosis in breast cancer patients aged <40 years. Methods: Using the Surveillance, Epidemiology, and End Results program, we included patients aged <40 years with tumor size ≤5 cm, node ne...

Full description

Bibliographic Details
Main Authors: Kai-Hua Liu, Lei Zhang, Jian-Xian Chen, Chen-Lu Lian, Jun Wang, Zhen-Yu He, San-Gang Wu
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:Breast
Subjects:
Breast cancer
Oncotype
Age
Prognosis
Chemotherapy
Recurrence score
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977619312202

Internet

http://www.sciencedirect.com/science/article/pii/S0960977619312202

Similar Items